Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Internal Medicine | Oncology | Pathology | Urology | Conference News

Back to Journal Articles

AACR: Long-Term Selenium Intake Tied to Prostate Cancer

Last Updated: April 10, 2013.

 

Decrease in advanced disease risk is associated with increasing quintiles of toenail mineral

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Toenail selenium, which reflects long-term selenium intake, is associated with a decrease in the risk of advanced prostate cancer, especially during later follow-up, according to a study presented at the annual meeting of the American Association for Cancer Research, held April 6 to 10 in Washington, D.C.

WEDNESDAY, April 10 (HealthDay News) -- Toenail selenium, which reflects long-term selenium intake, is associated with a decrease in the risk of advanced prostate cancer, especially during later follow-up, according to a study presented at the annual meeting of the American Association for Cancer Research, held April 6 to 10 in Washington, D.C.

Milan S. Geybels, from Maastrich University in the Netherlands, and colleagues examined the correlation between toenail selenium and the risk of advanced prostate cancer using data from 58,279 men, aged 55 to 69 years, from the Netherlands Cohort study. A total of 898 cases of advanced prostate cancer were identified during 17.3 years of follow-up.

The researchers found that the risk of advanced prostate cancer was reduced with increasing quintiles of toenail selenium (hazard ratios, 1.00 [reference], 0.69, 0.45, 0.32, and 0.24; P for trend < 0.01). For men diagnosed during later follow-up, the correlation was more pronounced, with adjusted hazard ratios of 0.91 for men diagnosed at less than six years; 0.85 for men diagnosed at six to 12 years; and 0.77 for men diagnosed after more than 12 years of follow-up.

"Our findings need to be replicated in further prospective studies, with an extended follow-up for the assessment of incident advanced prostate cancer, and with a wide range of toenail selenium that includes low selenium levels," Geybels said in a statement. "If our results can be confirmed, a prevention trial of selenium and prostate cancer in a low-selenium population may be justified."

Press Release
More Information

Health News Copyright © 2013 HealthDay. All rights reserved.


Previous: AACR: Exercise Tied to Reduced Estrogens Post-Menopause Next: Sleep Apnea Tied to Behavioral, Attention Problems in Youths

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.